Based on published reports on the 5-Lox inhibitory effect of WDL, we expected that WDL, like other 5-Lox inhibitors, will decrease viability and induce apoptosis in prostate cancer cells via inhibition of PKCε (33) but without inhibition of Akt (32). Here, AKT1 is linked to prostate carcinoma.